D-1342-2019 Class II Terminated

Recalled by Chiesi USA, Inc. — Cary, NC

FDA drug recall D-1342-2019 was initiated by Chiesi USA, Inc. on May 31, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications: Out of specification result for dissolution. The recall status is terminated (terminated Mar 8, 2021). Affected quantity: 2598 bottles.

Recall details

Product Type
Drugs
Report Date
Jun 19, 2019
Initiation Date
May 31, 2019
Termination Date
Mar 8, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2598 bottles

Product description

Zileuton Extended-Release Tablets, 600 mg, 120-count bottles, Rx only, Distributed by: Prasco Laboratories, Mason, OH 45040 USA; NDC 66993-485-32.

Reason for recall

Failed Dissolution Specifications: Out of specification result for dissolution.

Distribution pattern

Nationwide in the USA.

Code information

Lots: 3171856, Exp. 12/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1342-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1342-2019. Report a data issue: hello@regdatalab.com.